Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
批准号:
9899172
负责人:
Michael Stephen Trent
金额:
$74.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-05-22 至 2022-04-30
关键词:
AdjuvantAntibody titer measurementAntigen TargetingAntigensBacteriaBenchmarkingCell Culture TechniquesCessation of lifeClinicalCommunicable DiseasesDataDevelopmentDiphtheriaDiseaseEmulsionsEngineeringEscherichia coliExhibitsFerretsFeverFutureGenerationsGlycoconjugatesGlycolipidsHumanHydrophobicityImmune responseImmunityInfectionInflammatoryInflammatory ResponseInfluenzaInfluenza A virusInfluenza HemagglutininInnate Immune SystemLaboratoriesLibrariesLigandsLipid ALipopolysaccharidesLongevityMeasurementMembraneMethodsMindModelingModernizationMusNaturePersonal SatisfactionPoisonPoliomyelitisPopulationProcessProductionProteinsPublic HealthRecombinant DNARecording of previous eventsReportingSignal TransductionSmallpoxStructureSurfaceSurface AntigensSymptomsSystemTLR4 geneTechnologyTestingTetanusUnited States Food and Drug AdministrationUpdateVaccinatedVaccinationVaccine DesignVaccine ProductionVaccinesVariantVesicleVirusbasecombatcombinatorialcost effectivecytokinedesignefficacy testingeggimprovedin vivoinfluenza epidemicinfluenza outbreakinfluenza virus vaccineinfluenzavirusinnovationmicroorganismmulti-drug resistant pathogennew technologynovel vaccinespandemic diseasepandemic influenzapreventprotein purificationpublic health interventionreceptorseasonal influenzastemsuccesstooluniversal influenza vaccineuniversal vaccinevaccine candidatevaccine deliveryvaccine developmentvaccinology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Vaccination is perhaps the most effective public health intervention in the history of mankind. Over the past
200 years, there have been many accomplishments in vaccine development with successes against diseases
such as smallpox, polio, tetanus, diphtheria, and others. However, there is an ever-growing need for new
vaccine technologies to combat diseases that are difficult to target. Furthermore, vaccination may be the only
course of action to prevent infectious diseases caused by multi-drug resistant pathogens. The primary
objective of the current application is to develop a vaccine platform that allows for the display of both
engineered antigens and adjuvants on the surface of non-pathogenic E. coli. This platform permits the use of
whole bacteria and outer membrane vesicles (OMVs) as both vaccine production and vaccine delivery systems.
In the current application, this innovative, efficient, and cost-effective vaccine platform will be directly applied to
the production of a broadly protective, universal influenza vaccine.
Seasonal influenza epidemics cause millions of cases of severe infection per year worldwide and an
uncontrolled influenza pandemic could result in the death of tens of millions. The most effective approach to
protecting the population from influenza is through vaccination; however, current influenza vaccines are not
broadly protective and must be updated yearly in an inefficient, expensive, and laborious process. Our new
antigen/adjuvant bacterial display platform has the potential to overcome these weaknesses. The Specific
Aims of this proposal are (i) to engineer the bacterial surface of E. coli for display of targeted antigens and
adjuvants for protective vaccines, (ii) to engineer the production of polyvalent influenza vaccine offering
heterosubtypic immunity, and (iii) to test the efficacy and durability of protection induced by our engineered
universal influenza vaccines in ferrets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelope
-
批准号:10731444
-
项目类别:
-
资助金额:$67.71万
-
财政年份:2023
-
负责人:Michael Stephen Trent
-
依托单位:
Synthesis and transport of outer membrane components across the Gram-negative cell envelope
-
批准号:10680968
-
项目类别:
-
资助金额:$57.98万
-
财政年份:2023
-
负责人:Michael Stephen Trent
-
依托单位:
2022 Bacterial Cell Surfaces GRC/GRS
-
批准号:10374358
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Michael Stephen Trent
-
依托单位:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
-
批准号:10113527
-
项目类别:
-
资助金额:$53.93万
-
财政年份:2020
-
负责人:Michael Stephen Trent
-
依托单位:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
-
批准号:10542396
-
项目类别:
-
资助金额:$53.93万
-
财政年份:2020
-
负责人:Michael Stephen Trent
-
依托单位:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
-
批准号:10328269
-
项目类别:
-
资助金额:$53.93万
-
财政年份:2020
-
负责人:Michael Stephen Trent
-
依托单位:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
-
批准号:10159193
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2018
-
负责人:Michael Stephen Trent
-
依托单位:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
-
批准号:10403653
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2018
-
负责人:Michael Stephen Trent
-
依托单位:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
-
批准号:9917747
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2018
-
负责人:Michael Stephen Trent
-
依托单位:
Rethinking the barrier: How a Gram-negative bacterium alters its surface to become multidrug resistant
-
批准号:9102680
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:Michael Stephen Trent
-
依托单位:
Rethinking the barrier: How a Gram-negative bacterium alters its surface to become multidrug resistant
-
批准号:9090098
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2015
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio cholerae
-
批准号:8016612
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio cholerae
-
批准号:7763201
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio cholerae
-
批准号:8212148
-
项目类别:
-
资助金额:$32.17万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio cholerae
-
批准号:8630555
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio cholerae
-
批准号:7687065
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio Cholerae
-
批准号:9319104
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio Cholerae
-
批准号:9125719
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio cholerae
-
批准号:8730848
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
The Outer Surface of Vibrio cholerae
-
批准号:7557873
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2008
-
负责人:Michael Stephen Trent
-
依托单位:
海外基金